Prostate cancer decisions — 2026

The Board has remanded the issues of service connection for depression, a rating in excess of 20 percent for prostate cancer with voiding dysfunction, and service connection for obstructive sleep apnea with CPAP. The Veteran's claims are currently under review.

The Board has remanded the issues of service connection for depression, a rating in excess of 20 percent for prostate cancer with voiding dysfunction, and service connection for obstructive sleep apnea with CPAP. The Veteran's claims are currently under review.

The Veteran's service connection for prostate cancer and erectile dysfunction, as well as special monthly compensation based on loss of use of a creative organ, is granted effective April 10, 2024. The effective dates for the other claims are denied.

The Board denied service connection for prostate cancer as there was no evidence linking the condition to service, including exposure to herbicide agents or diesel fuel.

The Veteran's claim for an increased rating for bilateral open angle glaucoma with pseudophakia, status post tube shunt glaucoma surgery was denied. The Board found that the evidence did not show more than four incapacitating episodes in a 12-month period or visual acuity worse than 20/70 in either eye, which would warrant a higher rating. For prostate cancer, the Veteran's claim for service connection was also denied as there is no etiological link to his service.

The Veteran's prostate cancer and diabetes mellitus are presumed to be related to his service in Vietnam, as he was exposed to herbicide agents. The erectile dysfunction is not considered presumptively related to the diabetes.,The urinary tract disability is also presumed to be related to the diabetes.

The Board has decided to remand the case due to an inadequate medical opinion regarding the Veteran's prostate cancer and its relation to service, specifically TERA exposure. The claim will be returned for further evaluation.

The Veteran's service-connected disabilities have rendered him unable to secure and follow substantially gainful employment, warranting a finding of TDIU effective January 1, 2020.

The Veteran's prostate cancer, including its residuals, is granted as service-connected due to in-service exposure to AFFF foam.,Service connection for bilateral hearing loss and scarring tissue on lungs is denied.

The Veteran's prostate cancer is granted as service connected due to exposure near the Korean DMZ during a period of presumed herbicide agent exposure.

The Veteran's earlier effective dates for service connection of chronic sinusitis, prostate cancer, and erectile dysfunction have been granted.,Prostate cancer was initially awarded an effective date of August 10, 2022. The Veteran now has an earlier effective date of July 13, 2022.

The Veteran's service-connected status post excision of skin cancer is granted. The initial compensable evaluation for his service-connected prostate cancer is denied.

The Board has remanded the claims for an evaluation in excess of 20 percent for diabetic peripheral neuropathy of the bilateral lower extremities and for loss of teeth. The anterior trunk scar is rated at 10 percent, but no higher.

The Veteran's prostate cancer and erectile dysfunction have been granted service connection, along with SMC based on loss of use of a creative organ. The claim for SMC at the housebound rate is being remanded.

The Veteran's prostate cancer was not service-connected because there was no evidence of herbicide exposure during service and the condition did not manifest within one year after service. The Board found that the Veteran did not qualify for a presumption of exposure to herbicides.

The Veteran's prostate cancer is related to ionizing radiation during his active service. The Veteran's unspecified depressive disorder is caused by his prostate cancer. Ischemic heart disease and hemorrhagic stroke are not related to the Veteran's service, including exposure to ionizing radiation.,Ischemic heart disease and hemorrhagic stroke were denied as they did not have onset during active service and were not caused by active service; they did not manifest within one year of separation from active service.

The Board has remanded the case due to inadequate compliance with previous remand directives and a need for an addendum opinion regarding whether prostate cancer was aggravated by other service-connected conditions.

The Board has denied the Veteran's claim for service connection for prostate cancer, finding that there is not a link between his current condition and his military service. The evidence does not support a finding of radiation exposure or other toxic exposures during service.

The Veteran's prostate cancer was rated at 100% effective April 27, 2023. An earlier effective date for the award of service connection and a higher rating are denied.

The Board has remanded the Veteran's claims due to inadequate medical opinions provided by VA, which failed to address the Veteran's lay statements regarding his symptoms and injuries in service. The claims for left wrist condition including fracture, left ankle condition, right ankle condition, obstructive sleep apnea, gastroesophageal reflux disease (GERD), and residuals of prostate cancer are remanded.